Panion & Bf Biotech Inc. - PE Ratio
1760.TW
Price:
$62.2
Market Cap:
$5.33B
Panion & Bf Biotech Inc. is a biopharmaceutical firm operating in Taiwan, engaged in the production and distribution of a diverse range of pharmaceutical goods. Its offerings cater to several key therapeutic and wellness segments, including medical aesthetics, renal care, respiratory health, and gastrointestinal support. Beyond these, the company also provides oral medications, topical treatments, and an array of hygiene products like hand, mechanical, and skin disinfectants, alongside body lotions. Additionally, Panion & Bf Biotech supplies veterinary health solutions, notably surgical and dermatological prescriptions for animals. Established in 1976, the company maintains its corporate hea...[Read more]
Industry
Biotechnology
IPO Date
2007-12-20
Stock Exchange
TAI
Ticker
1760.TW
PE Ratio
[32.06]
ROE
[11.38%]
Current Ratio
[1.28]
Dividend Yield
[3.22%]
Enterprise Value
[5.50B]
Dividend History
The PE Ratio as of July 2026 (TTM) for Panion & Bf Biotech Inc. (1760.TW) is 32.06
According to Panion & Bf Biotech Inc.’s latest financial reports and current stock price. The company's current PE Ratio is 32.06. This represents a change of 11.76% compared to the average of 28.69 of the last 4 quarters.
Panion & Bf Biotech Inc. (1760.TW) Historical PE Ratio (quarterly & annually)
How has 1760.TW PE Ratio performed in the past?
The mean historical PE Ratio of Panion & Bf Biotech Inc. over the last ten years is 77.38. The current 32.06 PE Ratio has changed 4.04% with respect to the historical average. Over the past ten years (40 quarters), 1760.TW's PE Ratio was at its highest in in the March 2020 quarter at 1.82K. The PE Ratio was at its lowest in in the September 2020 quarter at -763.75.
Average
77.38
Median
55.85
Minimum
28.38
Maximum
232.94
Panion & Bf Biotech Inc. (1760.TW) PE Ratio by Quarter and Year
Discovering the peaks and valleys of Panion & Bf Biotech Inc. PE Ratio, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.
Maximum Annual Increase = 470.31%
Maximum Annual PE Ratio = 232.94
Minimum Annual Increase = -78.64%
Minimum Annual PE Ratio = 28.38
| Year | PE Ratio | Change |
|---|---|---|
| 2025 | 28.38 | -49.88% |
| 2024 | 56.62 | -54.50% |
| 2023 | 124.44 | 48.08% |
| 2022 | 84.04 | 47.51% |
| 2021 | 56.97 | -75.54% |
| 2020 | 232.94 | 470.31% |
| 2019 | 40.85 | -5.13% |
| 2018 | 43.05 | -21.83% |
| 2017 | 55.08 | 7.17% |
| 2016 | 51.39 | -78.64% |
Panion & Bf Biotech Inc. (1760.TW) Average PE Ratio
How has 1760.TW PE Ratio performed in the past?
The current PE Ratio of Panion & Bf Biotech Inc. (1760.TW) is less than than its 3-year, less than than its 5-year, and less than than its 10-year historical averages
3-year avg
69.81
5-year avg
70.09
10-year avg
77.38
Panion & Bf Biotech Inc. (1760.TW) PE Ratio vs. Peers
How is 1760.TW’s PE Ratio compared to its peers?
Panion & Bf Biotech Inc.’s PE Ratio is greater than Sinphar Pharmaceutical Co. Ltd. (18.91), greater than Savior Lifetec Corp. (26.86), greater than BioGend Therapeutics Co., Ltd. (-48.28), greater than OBI Pharma, Inc. (-0.98), less than Locus Cell Co., Ltd. (0), less than Orient Pharma Co., Ltd. (32.83), less than TaiGen Biopharmaceuticals Holdings Limited (114.27), greater than Formosa Optical Technology Co.,Ltd. (15.06), greater than Pharmosa Biopharm Inc. (-12.46), greater than Mycenax Biotech Inc. (-12.16),
| Company | PE Ratio | Market cap |
|---|---|---|
| 18.91 | $6.30B | |
| 26.86 | $6.50B | |
| -48.28 | $3.50B | |
| -0.98 | $3.97B | |
| 0 | $8.94B | |
| 32.83 | $6.62B | |
| 114.27 | $6.50B | |
| 15.06 | $5.33B | |
| -12.46 | $4.81B | |
| -12.16 | $5.31B |
Build a custom stock screener for Panion & Bf Biotech Inc. (1760.TW) and other stocks
One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Panion & Bf Biotech Inc. using the financials and key metrics that matter to you in a single view.
The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:
Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.
Get your free trial here.
Panion & Bf Biotech Inc. (1760.TW) and other stocks custom spreadsheet templates
The easiest way to analyze a company like Panion & Bf Biotech Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.
Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.
Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.
Frequently asked questions❓
What is the PE Ratio?
How can you use the PE Ratio?
What is Panion & Bf Biotech Inc.'s PE Ratio?
How is the PE Ratio calculated for Panion & Bf Biotech Inc. (1760.TW)?
What is the highest PE Ratio for Panion & Bf Biotech Inc. (1760.TW)?
What is the 3-year average PE Ratio for Panion & Bf Biotech Inc. (1760.TW)?
What is the 5-year average PE Ratio for Panion & Bf Biotech Inc. (1760.TW)?
How does the current PE Ratio for Panion & Bf Biotech Inc. (1760.TW) compare to its historical average?